Involvement of Kindlin-1 in cutaneous squamous cell carcinoma.
Giovana CarrascoIfigeneia StavrouMairi Treanor-TaylorHenry BeethamMartin LeeRoza MasalmehArtur Carreras-SoldevilaDavid HardmanMiguel O BernabeuAlexander von KriegsheimGareth J InmanAdam ByronValerie G BruntonPublished in: Oncogenesis (2024)
Kindler syndrome (KS) is a rare genodermatosis resulting from loss-of-function mutations in FERMT1, the gene that encodes Kindlin-1. KS patients have a high propensity to develop aggressive and metastatic cutaneous squamous cell carcinoma (cSCC). Here we show in non-KS-associated patients that elevation of FERMT1 expression is increased in actinic keratoses compared to normal skin, with a further increase in cSCC supporting a pro-tumorigenic role in this population. In contrast, we show that loss of Kindlin-1 leads to increased SCC tumor growth in vivo and in 3D spheroids, which was associated with the development of a hypoxic tumor environment and increased glycolysis. The metalloproteinase Mmp13 was upregulated in Kindlin-1-depleted tumors, and increased expression of MMP13 was responsible for driving increased invasion of the Kindlin-1-depleted SCC cells. These results provide evidence that Kindlin-1 loss in SCC can promote invasion through the upregulation of MMP13, and offer novel insights into how Kindlin-1 loss leads to the development of a hypoxic environment that is permissive for tumor growth.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- cell migration
- poor prognosis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- small cell lung cancer
- prognostic factors
- peritoneal dialysis
- magnetic resonance
- induced apoptosis
- magnetic resonance imaging
- gene expression
- dna methylation
- genome wide
- anti inflammatory
- case report